Schafiq Nabhani

456 total citations
11 papers, 290 citations indexed

About

Schafiq Nabhani is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Schafiq Nabhani has authored 11 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Schafiq Nabhani's work include Chronic Lymphocytic Leukemia Research (5 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Immune Cell Function and Interaction (5 papers). Schafiq Nabhani is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Immune Cell Function and Interaction (5 papers). Schafiq Nabhani collaborates with scholars based in Germany, Israel and Sweden. Schafiq Nabhani's co-authors include Arndt Borkhardt, Ute Fischer, Polina Stepensky, Andrea Hönscheid, Klaus Warnatz, Shoshana Revel‐Vilk, Bärbel Keller, Orly Elpeleg, Anne Rensing‐Ehl and Michael Gombert and has published in prestigious journals such as Blood, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Schafiq Nabhani

10 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Schafiq Nabhani Germany 9 223 92 46 44 43 11 290
Heiko Sic Germany 6 169 0.8× 52 0.6× 28 0.6× 36 0.8× 30 0.7× 6 236
Jenni E. Crowley United States 8 292 1.3× 41 0.4× 18 0.4× 44 1.0× 23 0.5× 8 365
Haowei Wang United States 9 258 1.2× 44 0.5× 33 0.7× 72 1.6× 19 0.4× 11 354
Attilio Gabbas Italy 8 134 0.6× 79 0.9× 36 0.8× 69 1.6× 29 0.7× 17 283
Leilani Zeumer United States 10 216 1.0× 58 0.6× 18 0.4× 101 2.3× 22 0.5× 12 336
Divya Punwani United States 8 197 0.9× 111 1.2× 17 0.4× 118 2.7× 21 0.5× 8 327
Rochelle M. Hinman United States 12 172 0.8× 137 1.5× 26 0.6× 102 2.3× 11 0.3× 13 338
Sun-Ok Yoon United States 10 283 1.3× 24 0.3× 31 0.7× 87 2.0× 24 0.6× 14 409
Wojciech Garncarz Austria 9 200 0.9× 72 0.8× 36 0.8× 232 5.3× 17 0.4× 11 414
Marijke Valkhof Netherlands 10 250 1.1× 116 1.3× 60 1.3× 204 4.6× 185 4.3× 14 516

Countries citing papers authored by Schafiq Nabhani

Since Specialization
Citations

This map shows the geographic impact of Schafiq Nabhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schafiq Nabhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schafiq Nabhani more than expected).

Fields of papers citing papers by Schafiq Nabhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Schafiq Nabhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schafiq Nabhani. The network helps show where Schafiq Nabhani may publish in the future.

Co-authorship network of co-authors of Schafiq Nabhani

This figure shows the co-authorship network connecting the top 25 collaborators of Schafiq Nabhani. A scholar is included among the top collaborators of Schafiq Nabhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Schafiq Nabhani. Schafiq Nabhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
3.
Meyer, Anja, et al.. (2019). Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis. Arthritis Research & Therapy. 21(1). 159–159. 32 indexed citations
4.
Schlütermann, David, Andrea Hönscheid, Schafiq Nabhani, et al.. (2018). EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency. Frontiers in Immunology. 9. 2400–2400. 32 indexed citations
5.
Nabhani, Schafiq, Hagit Miskin, Carina Levin, et al.. (2017). STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds. Clinical Immunology. 181. 32–42. 33 indexed citations
6.
Nabhani, Schafiq, Sebastian Ginzel, Hagit Miskin, et al.. (2015). Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease. Haematologica. 100(9). 1189–1198. 11 indexed citations
7.
Revel‐Vilk, Shoshana, Ute Fischer, Bärbel Keller, et al.. (2015). Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation. Clinical Immunology. 159(1). 84–92. 62 indexed citations
8.
Duggimpudi, Sujitha, Erik Larsson, Schafiq Nabhani, Arndt Borkhardt, & Jessica I. Hoell. (2015). The Cell Cycle Regulator CCDC6 Is a Key Target of RNA-Binding Protein EWS. PLoS ONE. 10(3). e0119066–e0119066. 10 indexed citations
9.
Kuhlen, Michaela, Andrea Hönscheid, Schafiq Nabhani, et al.. (2015). De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly. Clinical Immunology. 162. 27–30. 30 indexed citations
10.
Stepensky, Polina, Anne Rensing‐Ehl, Shoshana Revel‐Vilk, et al.. (2014). Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency. Blood. 125(5). 753–761. 57 indexed citations
11.
Nabhani, Schafiq, Andrea Hönscheid, Prasad T. Oommen, et al.. (2014). A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome. Clinical Immunology. 155(2). 231–237. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heiko Sic Breakdown of academic impact, for papers by Jenni E. Crowley Breakdown of academic impact, for papers by Haowei Wang Breakdown of academic impact, for papers by Attilio Gabbas Breakdown of academic impact, for papers by Leilani Zeumer Breakdown of academic impact, for papers by Divya Punwani Breakdown of academic impact, for papers by Rochelle M. Hinman Breakdown of academic impact, for papers by Sun-Ok Yoon Breakdown of academic impact, for papers by Wojciech Garncarz Breakdown of academic impact, for papers by Marijke Valkhof
Rankless by CCL
2026